1. Introduction
===============

*Subtilisin*-like pro-protein convertases (*PC*s) are the major endoproteolytic processing enzymes that mediate the biosynthesis of a great variety of secreted and membrane proteins. These proteins processed by *PC*s are involved in embryogenesis, gene expression, cell cycle, programmed cell death, intracellular protein targeting, and endocrine/neural functions ([@bib28], [@bib18]). These precursor molecules need to undergo a series of processing steps that involve multiple processing enzymes ([@bib19], [@bib3]). The multi-protein family of mammalian serine proteases is responsible for these proteolytic maturation events. They are expressed together or separately in functional cells from both vertebrates and invertebrates. The mammalian *PC*s have been demonstrated to be involved in several diseases, *i.e.* HIV, hepatitis B, severe acute respiratory syndrome (SARS), anthrax, cancer, Alzheimer\'s disease, arthritis, stroke, glaucoma, and diabetes ([@bib20], [@bib27], [@bib12], [@bib26], [@bib17], [@bib13]).

Pro-protein convertase-2 (*PC2*) and carboxypeptidase-E (*CPE*) are expressed widely in neuroendocrine tissues and play a major role in the proteolytic processing ([@bib9]). [@bib23] and [@bib14] reported that mouse or rat *proPC2* with 637 amino acid residues (74 kDa) cleaves into mature *PC2* with 529 amino acid residues (64 kDa) in adequate conditions, such as 5.0 pH, higher Ca^2+^, and other *PC*s. There is about 96.55% identity between human and mouse *PC2*, or 99.53% identity between mouse and rat *PC2* in amino acid sequence ([@bib22], [@bib21], [@bib15]). [@bib8] and [@bib10] reported that the human and rat *proCPE* protein sequence with 476 amino acid residues (56 kDa) are highly conserved (99.58% identity between them). The mature *CPE* protein is about 50 kDa. The soluble *CPE* (s*CPE*) is an exo-peptidase that cleaves neuroendocrinopeptide with C-terminal basic amino acid residue and produces active form of peptide hormone and neuropeptide ([@bib7], [@bib11]). The membrane-bound *CPE* (m*CPE*) functions as a sorting receptor in the trans-Golgi network (*TGN*). It facilitates the sorting of pro-hormones into the regulated secretary pathway ([@bib30], [@bib6]). [@bib2] and [@bib16] reported that the maturation of *NPY* precursor needed the presence of *PC2* and *CPE*.

In our previous study on neurons and ischemia, we discovered the artificial differentiation of NS20Y or RGC-5 tumor cells caused the increase of *PC2* activity. There may seem certain relationship between the *PC* system and tumor differentiation. The *PC2*/*CPE*-mediated processing system in the tumor cells and their corresponding mature tissues was evaluated in the paper.

2. Materials and methods
========================

2.1. Cell line and differentiation
----------------------------------

Retina ganglion cell-5 tumor cell (RGC-5) is transformed from rat retina ganglion cell. *NS20Y* tumor cell is neuroblastoma one from mouse brain cortex. They were grown in higher glucose DMEM medium containing 10% fetal calf serum (FCS) (Invitrogen Co.), 20 mM [l]{.smallcaps}-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 500 μM G418 at 37 °C in a 5% CO~2~ incubator. The differentiation of RGC-5 tumor cells was achieved by incubating cells in the DMEM--FCS medium containing 0.1 μM staurosporine (Sigma Co.) for 24 h and *NS20Y* cells were differentiated for 24-h in 1 mM dibutylyl cyclic AMP (Yamasa Chiba, Japan). Breast tumor cell line RM1 was cultured in the DMEM medium containing 10% FCS.

2.2. Immunocytochemistry
------------------------

The cultured cells were performed fluorescent *ICC*. Because the fluorescent *ICC* results of tissue sections were not good, the Envision method was used for the section *ICC*.

### 2.2.1. Fluorescent *ICC*

*PC2*, *CPE*, or *preproNPY* fluorescent *ICC* on cultured RGC-5 or NS20Y cells was analyzed by using FISH protocol ([@bib29]). Briefly, cultured cells in dish were washed three times with PBS, and then quenched for 5 min in the acidified ethanol solution (ethanol:acetic acid = 1:2) at −20 °C. After incubated for 20 min at room temperature in PBS containing 3% Tween X-100, a 30 min pre-incubation was completed in a blocking solution containing 2% horse serum, 0.1% BSA, and PBS. An appropriate primary antibody (*PC2*, *CPE*, or *preproNPY* antibody 1:1000, 2000, or 2000 diluted with the blocking solution, respectively) were incubated at 4 °C overnight. The next day, after washed three times with PBS for 15 min, they were incubated for 2 h with an appropriate Cy3-conjugated secondary antibody (1:380 diluted with the blocking solution, Vector Co.). After the cells were washed three times for 30 min with PBS, they were mounted with the mounting medium DAPI (4′,6-diamidino-2-phenylindole, Vectashield Co.) to stain nuclei. Fluorescent signals in the culture cells were examined and documented with an epifluorescence microscope (Leica Microsystems Inc.) attached with a magnified digital color camera (ChipCoolers Co.). The fluorescent signals of nuclei and positive portion were merged into our figures.

### 2.2.2. Envision method for *ICC*

The Envision method was performed by using an *ICC* kit (Beijing Zhengshan Biotech Co.). In our study, the method was better to wax tissue sections rather than cultured cells. So the sections used the Envision method for *ICC*. The wax sections were dried for 2 h at 37 °C in an electric drying oven. After the sections were soaked in turn into 1,2-dimethylbenzene solution three times for 30 min, 100% ethanol two times for 20 min, 90--70% ethanol one time for 10 min, respectively, they were washed one time with water and incubated 20 min in a dark room by adding 3% hydrogen peroxide on tissue. The sections were washed one time for 5 min with water and three times with PBS for 15 min. After incubated for 30 min at room temperature by adding 50 μl of primary antibodies (*PC2*, and *CPE*, *preproNPY* antibodies diluted into 1:1000 and 1:2000 with PBS solution), the sections were washed three times for 15 min with PBS. After incubated for 30 min at room temperature by adding the secondary antibody (ChemMateTMEnVision+/HRP), the sections were washed three times for 15 min with PBS. 50 μl of DAB working solution was added on tissue and incubated for 10 min at room temperature and the sections were washed in water. The sections were stained with hematoxylin and then de-watered in turn with 70--100% ethanol for 10 min each one. The Envision procedure was finished after the sections were soaked into 1,2-dimethylbenzene solution three times for 30 min and mounted with a mounting medium (neutral balsam, Shanghai Biaoben Model Co., China).

2.3. Tissue isolation and sample preparation
--------------------------------------------

Rat retina tissue and mouse brain cortex were taken, respectively from 250--300 g S-D rat and 20--25 g Kunming mouse from Nanfang Medical University. Human breast adenocarcinoma tissues and their normal breast tissues were donated by Dr. Huan-Xin Liu and Dr. Juan-Hui Zhang from Guangdong Armed Police Hospital. The fresh tissues were preserved at −80 °C for Western blot and *PC2* activity analysis. *PC2*, *CPE* and *preproNPY* protein expression levels were compared among mature retina tissue, RGC-5 tumor cells and its differentiation cells, or brain cortex tissue, NS20Y tumor cells and its differentiation cells, or mature breast tissue, breast tumor cell RM1, and breast adenocarcinoma tissue.

2.4. *PC2* enzymatic assay
--------------------------

Analysis of *PC2* activity followed a modulated protocol according to [@bib1]. The whole reaction volume was 100 μl. Tissues or cells were homogenized with a buffer containing 50 mM Tris--HCl (pH 7.5), 1% Triton X-100, 10% glycerol and a cocktail of protease inhibitors (aprotinin 1 μM, PMSF 1 mM, benzamidine 1 mM). To control the detergent concentration in the reaction buffer, 10 μl of protein supernatant was incubated with 200 μM [l]{.smallcaps}-pyroglutamyl-Arg-Thr-Lys-Arg-7-amino-4-methyl-coumarin in 100 mM sodium acetate (pH 5.0) and 1 mM CaCl~2~. All incubations were carried out at 37 °C for 4 h. In parallel incubations, 2 μM final concentration of CT peptide (SVNPYLQGKRLDNVVAKK, a *PC2*-specific inhibitor derived from the C-terminus of *7B2* protein) was used. The release of 7-amino-4-methylcoumarin was measured by using a Spectra Max GEMINI spectrofluorimeter (Molecular Devices Co.; *λ* ~ex~  = 360 nm, *λ* ~em~  = 480 nm). The amount of product formed was calculated by using free 7-amino-4-methylcoumarin as a standard. The activity inhibited by CT peptide was taken as *PC2* activity.

2.5. Western blot analysis
--------------------------

To prevent from serum contamination from medium, cells in dishes were washed one time with warm PBS and then suspended softly with cold PBS. After the cell suspension was centrifuged at 6000 rpm for 6 min at 4 °C, the cell pellet was collected. Tissue was homogenized with a 2-ml glass homogenizer. Proteins were extracted from tissue homogenates or cultured cell pellet with the same buffer as *PC2* activity. After tissue homogenate or cell lysate was subjected to 1 cycle of freezing--thawing--vortex to further destroy their structures, they were centrifuged at 10,000 ×  *g* for 10 min at 4 °C to collect supernatant. Protein concentration of the supernatant was determined by the Bradford method (Bio-Rad Laboratories Co.). Proteins (50 μg per gel lane) were fractionated by SDS--PAGE (150 V for 2 h), blotted onto a PVDF membrane (Millipore Co., USA) (166 mA for 2.5 h), and probed with an appropriate primary antibody. The antibody bound to the membrane was detected with the enzyme-catalyzed chemiluminescence (ECL) method (Pierce Co.). The membrane was cut for ECL according to the molecular weights of the detected proteins. To verify the equality of protein loadings among different samples to be compared, the blotted membrane was detected with β-actin antibody as control. Rabbit antiserum against *proPC2* (amino acids 611--638, diluted in 1:1000) (donated by Dr. An Zhou) or antibodies against *preproNPY* (amino acids 68--97, diluted in 1: 2000) and *CPE* (diluted in 1:2000) were used. The *CPE* or *preproNPY* antibody was purchased from Research Diagnostics Inc.

3. Results
==========

3.1. Differentiation of RGC-5 or NS20Y cell
-------------------------------------------

NS20Y or RGC-5 undifferentiated cells were induced differentiation in 1 mM dibutylyl cyclic AMP or 0.1 μM staurosporine for 24 h. The morphology of RGC-5 cells is similar to that of NS20Y cells. The undifferentiated cells are round and spindle shape in a light microscope. There is no dendrite on the body and granule in the cell ([Fig. 1](#fig1){ref-type="fig"}A). The differentiated cells are polygonal shape and have many dendrites on the body. There are many granules in the body and dendrites ([Fig. 1](#fig1){ref-type="fig"}B). Dendrites of the different cells linked with each other.Fig. 1Differentiation of NS20Y or RGC-5 cell (mag. 15× 10 times). (A) Undifferentiated cells and (B) differentiated cells.

3.2. *ICC* results
------------------

The *ICC* results of the cultured cells showed that *PC2*, *CPE* and *preproNPY* had sub-cellular redistribution along the cell body and tips ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"} ). The *ICC* results of NS20Y or RGC-5 cells were similar. In the differentiated cells, the up-regulations of *CPE* and *preproNPY* protein levels were observed ([Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}). Because the *ICC* results on mouse cortex neuron were similar to those of mature rat retina, the *ICC* results of mature mouse cortex tissue were only showed in the paper. Compared with the *ICC* results of breast adenocarcinoma tissue, the mature tissues (rat retina, mouse brain cortex, or normal breast) showed higher *PC2* activity, more *proPC2*, less *CPE*, and less *preproNPY* protein expression level ([Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"}, [Fig. 7](#fig7){ref-type="fig"}, [Fig. 8](#fig8){ref-type="fig"} ).Fig. 2*PC2* fluorescent *ICC* analyses of the cultured cells (merged, mag. 40× 10 times). (A) Undifferentiated cells and (B) differentiated cells. White arrowheads indicate positive portion in cell (red portion). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)Fig. 3*CPE* fluorescent *ICC* analyses of the cultured cells (merged, mag. 40× 10 times). (A) Undifferentiated cells and (B) differentiated cells. White arrowheads indicate positive portion in cell (red portion). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)Fig. 4*preproNPY* fluorescent *ICC* analyses of the cultured cells (merged, mag. 40× 10 times). (A) Undifferentiated cells and (B) differentiated cells. White arrowheads indicate positive portion in cell (red portion). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)Fig. 5*PC2*, *CPE*, and *preproNPYICC* analyses of mouse cortex neuron (Envision method, mag. 100× 10 times). (A) *PC2ICC* staining; (B) *CPEICC* staining; (C) *preproNPYICC* staining. Black arrowheads indicate positive cell (yellow portion). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)Fig. 6*PC2ICC* analysis of breast tissue (Envision method, mag. 100× 10 times). (A) Normal tissue and (B) adenocarcinoma tissue. Black arrowheads indicate positive cell (yellow portion). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)Fig. 7*CPEICC* analysis of breast tissue (Envision method, mag. 100× 10 times). (A) Normal tissue and (B) adenocarcinoma tissue. Black arrowheads indicate positive cell (yellow portion). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)Fig. 8*preproNPYICC* analysis of breast tissue (Envision method, mag. 100× 10 times). (A) Normal tissue and (B) adenocarcinoma tissue. Black arrowheads indicate positive cell (yellow portion). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)

3.3. Western blot results
-------------------------

50 μg of protein was loaded in SDS--PAGE lane and transferred on PVDF membrane. In the comparative experiments, more *proPC2* protein expression in the mature tissues and more *proCPE* protein expression in the tumor cells or tissue were observed ([Fig. 9](#fig9){ref-type="fig"}, [Fig. 10](#fig10){ref-type="fig"}, [Fig. 11](#fig11){ref-type="fig"} ). *preproNPY* protein expression were observed in the tumor cells or 5 of 8 adenocarcinoma tissue specimens, but no expression of the protein was observed in the mature tissues ([Fig. 9](#fig9){ref-type="fig"}, [Fig. 12](#fig12){ref-type="fig"} ). Compared with the NS20Y or RGC-5 undifferentiated cells, less *proPC2*, more *proCPE* and more *preproNPY* protein expressions were observed in the differentiated cells ([Fig. 9](#fig9){ref-type="fig"}A).Fig. 9Western blot analyses of *PC2*, *CPE* and *preproNPY* proteins. (A) Expression in NS20Y or RGC-5 cells. BD: undifferentiated cells; D: differentiated cells. (B) Expression in mature retina or brain cortex tissue. Protein markers 14.4--97 kDa or 3.5--45 kDa were used for *PC2* and *CPE* or *preproNPY* analysis.Fig. 10Western blot analysis of *proPC2* protein in breast tissue. (A) *ProPC2* protein band intensity statistics (*n* = 8). \**P* \< 0.05 *vs.* normal breast tissue (paired *t*-test). (B) Western blot picture of *proPC2* protein. Lane 1: normal breast tissue; Lane 2: breast adenocarcinoma tissue; Lane RM1: breast tumor cell RM1; protein markers 14.4--97 kDa.Fig. 11Western blot analysis of *proCPE* protein in breast tissue. (A) *proCPE* protein band intensity statistics (*n* = 8). \**P* \< 0.05 *vs.* normal breast tissue (paired *t*-test). (B) Western blot picture of *proCPE* protein. Lane 1: normal breast tissue; Lane 2: breast adenocarcinoma tissue; Lane RM1: breast tumor cell RM1; protein markers 14.4--97 kDa.Fig. 12(A) Western blot analysis of *preproNPY* protein in breast tissue (*n* = 8). Lane 1: normal breast tissue; Lane 2: breast adenocarcinoma tissue; Lane RM1: breast tumor cell RM1; protein markers 3.5--45 kDa. (B) *PC2* activity analysis of breast cells (*n* = 3) and tissues (*n* = 8). \**P* \< 0.05 and \*\**P* \< 0.01 *vs.* normal breast tissue (paired *t*-test).

3.4. *PC2* activity
-------------------

*PC2* activity showed significant difference between NS20Y or RGC-5 undifferentiated cells and its differentiated cells or the corresponding mature tissues (*P*  \< 0.05, *P*  \< 0.01) ([Fig. 13](#fig13){ref-type="fig"} ). Compared with the undifferentiated cells, the artificially differentiated cells showed higher *PC2* activity (*P*  \< 0.05). Compared with the normal breast tissue, the breast adenocarcinoma tissue or breast tumor cell RM1 showed lower *PC2* activity (*P*  \< 0.05, *P*  \< 0.01) ([Fig. 12](#fig12){ref-type="fig"}B). The differentiated cell or the mature tissues showed higher or the highest *PC2* activity whereas the tumor tissue or cells showed lower *PC2* activity.Fig. 13*PC2* activity analysis of tumor cells or tissues (*n* = 3). (A) RGC-5 cells and retina tissue. (B) NS20Y cells and mouse brain cortex tissue. \**P* \< 0.05 and \*\**P* \< 0.01 *vs.* result of tumor cell (*t*-test).

4. Conclusion
=============

*PC2* is one major endoproteolytic enzyme and *CPE* is an exoproteolytic one. When precursor molecule is endoproteolyzed by *PC*s, the soluble *CPE* recognizes the specific basic residue at the C-terminus and processes it. *NPY* molecule is one of the most abundant peptides found in the mammalian tissue ([@bib4], [@bib5]). Its maturation is subjected to the processing of *PC2* and *CPE*. *preproNPY* has 97 amino acid residues in mouse and human, 98 amino acid residues in rat. The isoelectric point (p*I*) of *preproNPY* is 11.1. The Western blot result of *preproNPY* peptide indicated that its specific band on SDS--PAGE was close to 17 kDa, which is because the higher p*I* of the peptide formed a larger molecule by combining with more SDS molecule. The electric mobility is very similar with the *GHRH* analogs we ever reported ([@bib24]). In the study on *PC2* activity, the leupeptin in the Berman buffer strongly inhibits *PC2* activity and there is lower *PC2* activity in the tumor cells. In order to obtain the reliable results, the Berman protocol was modulated.

RGC-5 or NS20Y cells were usually used in the *in vitro* study on retina or brain cortex neuron. For the cell cultures, 500 μM of G418 was added in the DMEM medium, which was because the cell lines were thought not to be in purity. The cells were kept in purity by adding G418. In our previous publication ([@bib25]), we discovered that there was a close relationship between the *PC* system and tumor. So the *PC2*/*CPE*-mediated processing was evaluated in mature tissues and tumor cells or tissues.

The experimental results indicated that the differentiated cells or tissues showed higher or highest *PC2* activity. In the comparative experiments, more *proPC2* protein expression in the mature tissues and more *proCPE* and high *preproNPY* protein expression in the tumor cells or tissue were observed, but no expression of *preproNPY* was observed in the mature tissue, which suggested the mature tissues have a stronger *PC2*/*CPE*--mediated pro-protein processing ability. As long as intracellular p*roNPY* protein occurs, the strong *PC2*/*CPE*-mediated processing system processes the precursor into *NPY*, whereas the weak *PC2*/*CPE*-mediated pro-protein processing level in the tumor tissues or cells leads to the aggregations of *proCPE* and *preproNPY* proteins. In the research the cell or tissue *ICC* results collaborated with the Western blot ones. We predict that there is a weak or uneven *PC*s system in tumor. The microenvironment formed in tumor was different from normal mature tissue. So the profile of tumor may result from not only up- or down-regulation(s) of component(s), but also the difference of the construct ratio of the functional molecules in tumor tissue should be considered. We predict that the increase of *PC2* activity in tumor cell may induce its differentiation.

The differentiated cells in our research showed higher *PC2* activity, less *proPC2*, more *proCPE* and high *preproNPY* protein expressions compared with RGC-5 or NS20Y undifferentiated cells, which suggested that the artificial differentiations were different from the differentiation of mature tissue. The staurosporine or dbcAMP reagent promoted the maturation of *proPC2* into *PC2* and induced the aggregations of *proCPE* and *preproNPY* proteins. The differentiations are more similar with "cell stressing induced by oxygen and glucose deprivation" ([@bib25]). The artificial differentiations may be false. But we also did not know why the increase of *PC2* in the differentiated cells accompanied the aggregations of *proCPE* and *preproNPY* proteins.

*proPC2* and *proCPE* or *preproNPY* protein in the experiments appeared to express differently in the cells or tissues, which may be that the mature *PC2* and *CPE* function accordingly. Because the transformation of *proPC2* into *PC2* is far slower than that of *proCPE* into *CPE*, when high *PC2* activity (more *proPC2*) is necessary in function, more *CPE* (less *proCPE*) should be accompanied. The more *PC2*-*CPE* quickly processes the substrate *proNPY* molecule. Similarly, less *PC2* causes the aggregations of *proCPE* and *preproNPY* proteins.
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